Form 4: Sanara MedTech CEO's Tax Withholding Transaction

Sanara MedTech Inc.'s CEO, Seth D. Yon, reported a transaction involving the withholding of 491 common shares to cover tax obligations related to restricted stock vesting.

Summary

• CEO Seth D. Yon reported a transaction on March 1, 2026, involving Sanara MedTech Inc. common stock.
• 491 shares of common stock were withheld by the issuer to satisfy tax withholding obligations.
• This withholding was in connection with the annual vesting of 1,446 shares of restricted stock previously granted to Mr. Yon.
• The per-share value assigned to the withheld shares was $20.44, reflecting the price on the vesting date as reported on the Nasdaq Capital Market.
• No shares were issued or sold in this transaction; it was solely for tax purposes.
• Following this transaction, Seth D. Yon beneficially owns 88,487 shares of Sanara MedTech Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard administrative transaction for tax purposes related to executive compensation, with no direct impact on company operations or strategic direction.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as tax-related withholdings upon restricted stock vesting, are common in executive compensation structures across various industries. These transactions typically do not reflect a change in management's investment sentiment but rather a standard administrative process.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related transaction for executive compensation.

Key Dates

Recommendation

This Form 4 filing details a routine tax withholding transaction for Sanara MedTech Inc.'s CEO, Seth D. Yon, upon the vesting of restricted stock. Such administrative transactions are common and do not typically indicate a change in the company's fundamentals or management's long-term outlook. Therefore, it provides no new information to warrant a change in investment recommendation, maintaining a 'hold' stance based solely on this filing.

Keywords

Sanara MedTech, SMTI, Form 4, insider transaction, stock withholding, restricted stock, executive compensation, Seth D. Yon